Bayer Korea punished for exaggerated ads

The Korea Food and Drug Administration has recently reproved Bayer Korea for advertising its vitamin product Redoxon chewable tablet from December last year to April this year, although the company was ordered not to advertise the product due to false or exaggerated ads last year.

The authorities have meted out its administrative disposition to withdraw Redoxon from the market.

The KFDA w...